Related Experiment Video
Updated: Jan 25, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why
Matthew Bower1, Charles R Scoggins
1Division of Surgical Oncology, Department of Surgery University of Louisville School of Medicine, Louisville, KY 40202, USA.
Abstract:
Knowledge of the metastastic status of the regional nodes provides important prognostic information for patients with cutaneous melanoma. Sentinel lymph node (SLN) biopsy has become the standard method for staging the regional nodes of patients with melanoma. The decision algorithm for using SLN biopsy is based upon the primary tumor depth, and utilization of SLN biopsy can spare patients the potential morbidity associated with complete lymph node dissection. Current studies are investigating the possibility of further limiting the need for complete lymph node dissections in patients with positive sentinel nodes.

